Search / Trial NCT06234475

Smoking Cessation Program for the Elderly

Launched by THE UNIVERSITY OF HONG KONG · Jan 22, 2024

Trial Information

Current as of October 08, 2024

Recruiting

Keywords

Smoking Cessation Low Income Older Smokers Mobile Health Incentive Real Time Personalized Support Factorial Study

Description

Low-income older smokers are disproportionally harmed by tobacco use and the evidence of effectiveness of smoking cessation (SC) intervention for this deprived group is scarce. Leveraging evidence of effectiveness of mHealth support and financial incentives in other adults, the investigators propose a scalable mHealth and/or financial incentives model using age-friendly components for the deprived older smokers. The 2x2 factorial design consists of 2 interventions, including (1) smartphone mHealth support by scheduled age-friendly multimedia e-messages and real-time personalized behavioral...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Smokers aged 60 years or above;
  • 2. Currently smoking cigarettes or alternative tobacco products daily in the past 3 months with an exhaled carbon monoxide (CO) level ≥4ppm or salivary cotinine \>30 ng/ml;
  • 3. Have a mobile phone that can receive short message/messaging Service (SMS) or instant messages (IM);
  • 4. Having a household monthly income lower than the median income of domestic household in Hong Kong
  • 6. Hong Kong residents able to communicate in Chinese.
  • Exclusion Criteria:
  • 1. Smokers not physically nor mentally fit for communication;
  • 2. Smokers currently using SC services;
  • 3. Hospitalized smokers;
  • 4. Not having a mobile phone or perceived difficulty in using mobile phone or communication Apps

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0